Skip to content
Advertisement

FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly shares slipped Friday, Jan. 20, 2023, after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment. (AP Photo/Darron Cummings, File)

FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly shares slipped Friday, Jan. 20, 2023, after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment. (AP Photo/Darron Cummings, File)

Featured Photo Galleries